UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity

Annals of oncology, 2018-04, Vol.29 (4), p.1010-1015

2018

Link zum Volltext

Verfügbarkeit prüfen

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

Annals of oncology, 2018-12, Vol.29 (12), p.2393-2395

2018

Link zum Volltext

Verfügbarkeit prüfen

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

Gastroenterology research and practice, 2015-01, Vol.2015, p.273489-8

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular monitoring of response to imatinib (Glivec ) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission

Leukemia, 2003-09, Vol.17 (9), p.1687-1694

2003

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Leukemia, 2003-12, Vol.17 (12), p.2392-2400

2003

Link zum Volltext

Verfügbarkeit prüfen

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization

Leukemia, 2002-12, Vol.16 (12), p.2395-2399

2002

Link zum Volltext

Verfügbarkeit prüfen

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

Cancer, 2005-04, Vol.103 (8), p.1659-1669

2005

Link zum Volltext

Verfügbarkeit prüfen

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

Leukemia, 2002-09, Vol.16 (9), p.1579-1583

2002

Link zum Volltext

Verfügbarkeit prüfen

An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR

Haematologica (Roma), 2007-07, Vol.92 (7), p.970-973

2007

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and Therapy of Polycythemia Vera

Seminars in thrombosis and hemostasis, 2006-04, Vol.32 (3), p.267-275

2006

Link zum Volltext

Verfügbarkeit prüfen

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours : results of an extended phase-1 trial

British journal of cancer, 2007, Vol.97 (11), p.1475-1479

2007

Link zum Volltext

Verfügbarkeit prüfen

Relation of changes in D-dimer and other coagulation markers with changes in Marder Score after treatment of acute venous thrombosis with the low molecular weight heparin Certoparin or unfractionated heparin

Journal of thrombosis and haemostasis, 2003-07, Vol.1, p.P1878-P1878

2003

Link zum Volltext

Verfügbarkeit prüfen

Standardization of Preanalytical Factors for Minimal Residual Disease Analysis in Chronic Myelogenous Leukemia

Acta Haematologica, 2004-01, Vol.112 (1-2), p.30-33

2004

Link zum Volltext

Verfügbarkeit prüfen

ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia

Blood, 2001-11, Vol.98 (9), p.2879-2880

2001

Link zum Volltext

Verfügbarkeit prüfen

Molecular Surveillance of Chronic Myeloid Leukemia Patients in the Imatinib Era – Evaluation of Response and Resistance

Acta Haematologica, 2004-01, Vol.112 (1-2), p.85-92

2004

Link zum Volltext

Verfügbarkeit prüfen

Warty skin changes, chronic scrotal lymphoedema, and facial dysmorphism

BMJ case reports, 2010-05, Vol.2010 (may19 1), p.bcr0820092214-bcr0820092214

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission : Spotlight on imatinib as a model for signal transduction inhibitors

Leukemia, 2003, Vol.17 (9), p.1687-1694

2003

Link zum Volltext

Verfügbarkeit prüfen

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon [alpha]

Leukemia, 2002-09, Vol.16 (9), p.1579-1583

2002

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon ara-C

Leukemia, 2003-12, Vol.17 (12), p.2392-2400

2003

Link zum Volltext

Verfügbarkeit prüfen

Association of changes in D-dimer and other coagulation markers with changes in Marder score after treatment of acute venous thrombosis

Journal of thrombosis and thrombolysis, 2002-08, Vol.14 (1), p.73-78

2002

Link zum Volltext

Verfügbarkeit prüfen

14 - Rapid detection and identification of spoilage bacteria in beer

Brewing Microbiology, 2015, p.287-318

2015

Link zum Volltext

Verfügbarkeit prüfen

Rapid Detection and Identification of Spoilage Bacteria in Beer

Brewing Microbiology - Managing Microbes, Ensuring Quality and Valorising Waste, 2015, p.1-1

Hill Annie E

2015

Link zum Volltext

Verfügbarkeit prüfen

Aktuelle Therapiekonzepte bei chronischer myeloischer Leukämie Die Studie IV der Deutschen CML-Studiengruppe: Die Studie IV der Deutschen CML-Studiengruppe

Der Internist (Berlin), 2002-10, Vol.43 (10), p.1228-1244

2002

Link zum Volltext

Verfügbarkeit prüfen

Current therapy concepts in chronic myeloid leukemia. Study IV of the German CML Study Group

Der Internist (Berlin), 2002-10, Vol.43 (10), p.1228, 1231-1228

2002

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

PloS one, 2018-01, Vol.13 (1), p.e0191592-e0191592

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(80)
Buchkapitel
(2)

Sprache

Englisch
(61)
Deutsch
(22)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(58)
Science & Technology
(38)
Male
(31)
Life Sciences & Biomedicine
(30)
Female
(29)
Middle Aged
(24)
Aged
(21)
Adult
(18)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Hematology
(11)
Electrocardiography
(10)
Animals
(8)
Blood Pressure
(8)
Fusion Proteins, Bcr-Abl - Genetics
(8)
Multidisciplinary Sciences
(8)
Myocardial Infarction - Physiopathology
(8)
Science & Technology - Other Topics
(8)
Cardiovascular System & Cardiology
(7)
Heart
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

Molecular monitoring of response to imatinib (Glivec ) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon α

An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR

Diagnosis and Therapy of Polycythemia Vera

Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours : results of an extended phase-1 trial

Relation of changes in D-dimer and other coagulation markers with changes in Marder Score after treatment of acute venous thrombosis with the low molecular weight heparin Certoparin or unfractionated heparin

Standardization of Preanalytical Factors for Minimal Residual Disease Analysis in Chronic Myelogenous Leukemia

ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia

Molecular Surveillance of Chronic Myeloid Leukemia Patients in the Imatinib Era – Evaluation of Response and Resistance

Warty skin changes, chronic scrotal lymphoedema, and facial dysmorphism

Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission : Spotlight on imatinib as a model for signal transduction inhibitors

Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon [alpha]

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon ara-C

Association of changes in D-dimer and other coagulation markers with changes in Marder score after treatment of acute venous thrombosis

14 - Rapid detection and identification of spoilage bacteria in beer

Rapid Detection and Identification of Spoilage Bacteria in Beer

Aktuelle Therapiekonzepte bei chronischer myeloischer Leukämie Die Studie IV der Deutschen CML-Studiengruppe: Die Studie IV der Deutschen CML-Studiengruppe

Current therapy concepts in chronic myeloid leukemia. Study IV of the German CML Study Group

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

Suchergebnisse filtern